TAMMY ROQUE, MD
Medical Oncology Physician · SHERMAN, TX
Individual Active NPI 1376581330
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 682 | 224,987 | $15,649,104 | $4,262,888 | $3,393,215 |
| 2023 | 538 | 82,656 | $5,499,286 | $1,446,841 | $1,153,573 |
| 2022 | 797 | 231,256 | $12,801,692 | $3,302,996 | $2,632,141 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 27,030 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 19,000 | $56 | $45 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 17,200 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 14,680 | $31 | $25 |
| J1453 | Injection, fosaprepitant, 1 mg | 13,950 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 11,160 | $50 | $39 |
| J1756 | Injection, iron sucrose, 1 mg | 10,700 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 7,669 | $0 | $0 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 6,985 | $3 | $2 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 6,665 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 5,400 | $26 | $21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,970 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | H8588 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1518901115
- NPI 1346331063
- NPI 1497319636
- NPI 1346323888
- NPI 1447414776
- NPI 1063676245
- NPI 1730463324
- NPI 1518066521
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.